Major generic maker cuts production at a key plant

Taking stock of the drug industry, from the lab to the medicine chest

February 9, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Major generic maker Aurobindo cuts production at a key plant amid concerns over shortages The Aurobindo site in India manufactures more than 150 products, including essential injectables and eye drops for the U.S. market. By Ed Silverman STAT+ | Senators start work on Medicare physician payment reform A bipartisan group of senators is starting to work on long-term fixes to issues with how Medicare pays doctors. By Rachel Cohrs STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman Anna Moneymaker/Getty Images STAT+ | Key House Republican on health care plans exit from Congress Rep. Cathy McMorris Rodgers, who leads the House Energy & Commerce Committee, announced plans to leave Congress. By Rachel Cohrs

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser